Erythema Toxicum


Article Author:
Euripides Roques


Article Editor:
Magda Mendez


Editors In Chief:
David Wood
Andrew Wilt
Hajira Basit


Managing Editors:
Avais Raja
Orawan Chaigasame
Khalid Alsayouri
Kyle Blair
Radia Jamil
Erin Hughes
Patrick Le
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Hassam Zulfiqar
Navid Mahabadi
Hussain Sajjad
Steve Bhimji
Muhammad Hashmi
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Sarosh Vaqar
Mark Pellegrini
James Hughes
Beenish Sohail
Hajira Basit
Phillip Hynes
Sandeep Sekhon


Updated:
11/24/2018 11:43:55 AM

Introduction

Erythema toxicum neonatorum is a condition that has been described (rash) as early as the 15th century by a pediatrician named B. Metlinger. It has been associated with a reaction to meconium to the skin of the baby, and the name of the condition has changed several times over the years, from erythema populated to erythema dyspepsia and erythema neonatorum allergicum. In 1912, Dr. Karl Leiner, an Austrian pediatrician, named the condition erythema toxicum neonatorum and currently this is the denomination used for these skin findings.[1]

Etiology

Erythema toxicum neonatorum is a benign, self-limited, transient, evanescent eruption that occurs in approximately 48% to 72% of full-term infants. A 1986 study reported that 40.8% of 5387 Japanese neonates examined over a period of 10 years were identified as having erythema toxicum neonatorum. Preterm infants with birth weight less than 2500 grams are less likely to be affected.[2][3]

Epidemiology

While there is no racial predilection, males appear more commonly affected compared to females. In 356 Spanish newborns, 25.3% had erythema toxicum neonatorum (61.9% were males, and 38.1% were females). Recurrence is exceedingly rare, although there have been some reports of recrudescence within the first month of life. [4]

Pathophysiology

The etiology of this condition is completely unknown: a graft-versus-host reaction against maternal lymphocytes has been postulated as a possible mechanism, but recent studies failed to show the presence of maternal cells in these lesions. Another theory proposes an immune response to microbial colonization through the hair follicles as early as one day of age. Immunohistochemical study of lesions from 1-day-old infants supports the accumulation and activation of immune cells in erythema toxicum neonatorum lesions. A variety of inflammatory mediators such as IL-1alpha, IL-1beta, IL-8, eotaxin, aquaporins 1 and 3, psoriasin, nitric oxide synthetases 1, 2 and 3, and HMGB-1 have been associated with erythema toxicum neonatorum immunohistochemically. Tryptase-expressing mast cells, however not the cathelicidin antimicrobial peptide LL-37, have been located in erythema toxicum neonatorum biopsy specimens.

Histopathology

The pustules form below the stratum corneum or deeper in the epidermis and represent collections of eosinophils that also accumulate around the upper portion of the pilosebaceous follicle. The eosinophils can be demonstrated in Wright-stained smears of the intralesional contents. The pustules usually contain around 50% eosinophils, and it can approach up to a 95%. Cultures are sterile, no organisms are seen on Gram stain. Microscopic observation of the erythematous macules and patches shows superficial dermal edema with a mild diffuse and perivascular eosinophilic infiltrate. Papules display mild hyperkeratosis and a more pronounce edema with eosinophilic infiltration. Hair follicles, eccrine glands, and ducts tend to be strongly affected.

History and Physical

The lesions are firm, yellow-white, 1 to 3-mm papules or pustules with a surrounding irregular erythematous base. They also have been described as having a “flea-bitten appearance” or a papule surrounded by a sea of erythema. At times, splotchy erythema is the only manifestation. Lesions may be sparse or numerous and they can be either clustered in several sites or widely dispersed over much of the body surface. Erythema toxicum neonatorum has been described as consisting of two likely variations: an erythematous papular or a pustular variant. During the first day of presentation, macules tend to appear within and outside the erythematous lesions. It usually begins on the cheeks and rapidly spreads to the forehead, the rest of the face, chest, trunk, and extremities but there are several case reports of patients with erythema toxicum neonatorum lesions over the skin of the scrotum. The blotchy appearance ensues as the macules become confluent, sometimes resembling urticarial lesions on the trunk. The palms and soles are usually spared, this pattern of involvement may be correlated to the distribution of hair follicles. Clinicians have a harder time seeing erythema toxicum neonatorum in babies with darker skin. This makes the identification of the problem somewhat challenging. Erythematous macules often are evanescent, but when they persist, papules then tend to appear, papules also may arise as de novo. Some papules may become superficial, particularly on the skin of the back and abdomen. It is very uncommon for the pustules to become secondarily infected. The peak incidence occurs on the second day of life, but new lesions may erupt during the first few days as the rash waxes and wanes, although recurrences may occur in up to 11% of neonates. The onset may occasionally be delayed for a few days to weeks in premature infants. There is no systemic manifestation associated with the condition, and one might rarely see some eosinophilia in blood studies and counts as high as 18% have been reported.[5][6]

Evaluation

No laboratory work up is usually required as the diagnosis in most cases is clinical.

Treatment / Management

Treatment starts with education to the parents about the natural course of the condition: it is benign and will resolve without any sequelae. Because of the appearance of the rash creates great parental concerns, reassuring the parents has paramount significance.

Differential Diagnosis

Differential diagnosis to this condition includes sepsis, staphylococcal folliculitis, acne neonatorum, pyoderma, congenital candidiasis, herpes simplex, infantile acropustulosis, neonatal varicella, pustular miliaria,  miliaria cristalina, miliaria rubra, transient neonatal pustular melanosis (TNPM) and incontinentia pigmenti. 

Transient neonatal pustular melanosis and incontinentia pigmenti can be distinguished without any difficulty from erythema toxicum neonatorum. Transient neonatal pustular melanosis present at birth as does erythema toxicum neonatorum, but transient neonatal pustular melanosis (TNPM) involves the palms and soles, there is no erythematous component, and it shows only neutrophils with cytologic debris. However, both condition can present at the same time. Incontinentia pigment presents with vesicles filled with eosinophils, and it is more common in boys but is rarely pustular, and the appearance is in a linear pattern different from the pattern of erythema toxicum neonatorum. The distribution of the rash can also be useful to differentiate erythema toxicum neonatorum from infantile acropustulosis, while erythema toxicum neonatorum spares the palm and soles, the hallmark of infantile acropustulosis characteristically include the acral surfaces hence its name. Erythema toxicum neonatorum can be differentiated from miliaria rubra, a condition in which the vesicles are related to the sweat ducts rather than hair follicles and the lesions containing mononuclear cells rather than eosinophils. Congenital cutaneous candidiasis can also present at birth or in the first days of life, with a diffuse erythematous rash with overlying papules, pustules and vesicles, but the palms and soles are not spared.

Enhancing Healthcare Team Outcomes

Erythema toxicum is a benign self-limited skin disorder that is only seen in neonates. Unfortunately, many worried parents bring the child to the healthcare provider for treatment. The key to this disorder is parent education. The primary care provider, nurse practitioner, pharmacist and healthcare professionals in the emergency department need to reassure the parent that the disorder is harmless and will resolve spontaneously. The prognosis for most neonates is excellent, with the rash resolving in 10-14 days.[7]


Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Erythema Toxicum - Questions

Take a quiz of the questions on this article.

Take Quiz
Which of the following investigations may be needed to confirm a diagnosis of erythema toxicum?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A one-day old infant develops a rash mostly on the trunk. Initially, there were papules but pustules have developed, surrounded by erythematous skin. The infant is feeding well and the rest of the exam is normal. What would further evaluation reveal?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Erythema Toxicum - References

References

Reginatto FP,Muller FM,Peruzzo J,Cestari TF, Epidemiology and Predisposing Factors for Erythema Toxicum Neonatorum and Transient Neonatal Pustular: A Multicenter Study. Pediatric dermatology. 2017 Jul     [PubMed]
Reddy HB,Gandra NR,Katta TP, Cutaneous Changes in Neonates in the First 72 Hours of Birth: An Observational Study. Current pediatric reviews. 2017     [PubMed]
Rayala BZ,Morrell DS, Common Skin Conditions in Children: Neonatal Skin Lesions. FP essentials. 2017 Feb     [PubMed]
Ghosh S, Neonatal pustular dermatosis: an overview. Indian journal of dermatology. 2015 Mar-Apr     [PubMed]
Reginatto FP,DeVilla D,Muller FM,Peruzzo J,Peres LP,Steglich RB,Cestari TF, Prevalence and characterization of neonatal skin disorders in the first 72h of life. Jornal de pediatria. 2017 May - Jun     [PubMed]
Reginatto FP,Villa DD,Cestari TF, Benign skin disease with pustules in the newborn. Anais brasileiros de dermatologia. 2016 Apr     [PubMed]
Kanada KN,Merin MR,Munden A,Friedlander SF, A prospective study of cutaneous findings in newborns in the United States: correlation with race, ethnicity, and gestational status using updated classification and nomenclature. The Journal of pediatrics. 2012 Aug     [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Pediatrics-Medical Student. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Pediatrics-Medical Student, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Pediatrics-Medical Student, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Pediatrics-Medical Student. When it is time for the Pediatrics-Medical Student board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Pediatrics-Medical Student.